Sangamo Therapeutics Cash Flow Statement (2010-2025) | SGMOQ

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-45.94M-47.17M-47.70M-37.50M-43.98M-43.17M-53.16M-51.94M21.13M-114.51M-104.16M-60.30M-49.09M-36.13M10.67M-23.40M-30.60M-19.99M-34.93M-37.42M
Share-based Compensation (Quarter)
1.36M15.65M7.87M8.08M1.64M0.19M21.57M-21.30M1.11M0.19M19.95M-19.76M2.72M3.06M3.31M11.70M2.23M2.23M2.13M0.35M
Deferred Taxes (Quarter)
0.18M-0.14M0.02M-0.02M0.01M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
4.20M44.80M0.20M4.35M1.17M13.23M
Cash from Operations (Quarter)
-68.55M-52.57M-59.42M-52.71M-58.98M-53.98M-53.62M-57.05M-66.30M-60.71M-47.29M-50.54M-48.66M-26.88M11.76M-3.35M-26.15M-18.16M-28.50M-24.40M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
38.10M
Amortizatization of Intangibles (Quarter)
-0.82M-0.91M-0.66M-0.45M-0.16M-0.04M0.53M0.92M1.05M0.82M0.17M0.30M0.27M
Amortization of Deferred Charges (Quarter)
2.10M2.09M1.93M1.93M1.18M1.12M1.33M0.91M0.89M0.90M0.90M0.91M0.92M
Depreciation & Amortization (CF) (Quarter)
1.88M2.25M2.56M2.73M2.83M2.88M3.05M3.34M3.49M4.26M5.49M1.86M1.41M1.24M1.22M1.24M1.02M0.99M0.99M1.00M
Change in Working Capital
Change in Receivables (Quarter)
1.52M0.14M1.08M-1.95M0.93M-0.94M-1.48M-0.84M3.35M-4.31M-1.57M-0.23M-0.23M-0.11M9.91M-9.97M-0.16M0.01M0.15M-0.15M
Change in Accured Expenses (Quarter)
-3.83M0.62M-1.50M5.07M3.61M-10.23M5.39M2.17M-1.91M-1.20M-2.12M10.81M-2.56M-0.64M5.25M3.68M4.22M-3.92M4.00M-1.51M
Other Working Capital Changes (Quarter)
1.68M2.76M2.03M0.71M0.24M4.75M0.86M-0.94M-6.22M0.68M0.39M-5.10M-0.96M-1.47M-3.38M1.42M2.63M-1.24M1.84M-4.05M
Investing Activities
Capital Expenditures (Quarter)
2.95M12.26M5.21M2.86M2.26M-0.03M10.46M7.47M10.20M-5.29M-2.15M-2.31M0.46M-0.46M0.39M-0.15M0.23M-0.21M0.06M0.01M
Sales of Property, Plant and Equipment (Quarter)
0.35M1.48M
Change in Acquisitions & Divestments (Quarter)
144.37M178.73M186.52M93.27M70.30M98.05M86.64M-252.73M82.15M-82.15M19.74M34.73M-33.62M
Cash from Investing Activities (Quarter)
45.29M89.30M60.98M52.63M1.71M28.43M-13.46M42.61M35.73M42.47M37.63M37.71M35.84M0.13M0.23M1.32M-0.02M-0.06M-0.01M
Financing Activities
Other financing activities (Quarter)
1.82M1.88M0.88M1.07M0.07M0.02M0.03M22.52M-22.38M-0.15M0.29M0.18M0.00M52.01M
Cash from Financing Activities (Quarter)
15.23M10.02M5.49M2.11M-1.57M22.87M43.82M19.54M8.00M6.52M-0.10M0.17M22.12M-0.53M-0.20M6.99M8.13M28.61M19.20M14.80M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
15.65M-13.60M25.05M1.11M64.73M19.02M15.11M0.00M21.92M-0.07M10.36M11.23M-0.11M
Additional items
Exchange Rate Effect (Quarter)
-0.33M0.15M0.03M-0.12M0.22M0.13M0.13M0.78M0.37M0.31M-0.55M1.35M-0.67M-0.26M1.13M-2.25M1.28M2.73M0.04M0.04M
Change in Cash (Quarter)
-8.35M46.90M7.08M1.92M-58.62M-2.55M-23.14M5.87M-22.20M-11.41M-10.32M-11.31M8.63M-27.55M12.91M2.72M-16.74M13.16M-9.32M-9.58M
Free Cash Flow (Quarter)
-71.50M-64.83M-64.63M-55.57M-61.23M-53.96M-64.08M-64.52M-76.50M-55.42M-45.14M-48.23M-49.12M-26.42M11.37M-3.20M-26.38M-17.95M-28.56M-24.42M
Net Cash Flow (Quarter)
-8.03M46.75M7.05M2.03M-58.84M-2.68M-23.26M5.10M-22.57M-11.72M-9.77M-12.66M9.30M-27.29M11.79M4.96M-18.02M10.43M-9.36M-9.62M